74
Views
27
CrossRef citations to date
0
Altmetric
Special Report

An update on the immunopathogenesis of eosinophilic esophagitis

&
Pages 141-148 | Published online: 10 Jan 2014

References

  • Atkins D, Kramer R, Capocelli K et al. Eosinophilic esophagitis: the newest esophageal inflammatory disease. Nat. Rev. Gastroenterol. Hepatol.6, 267–278 (2009).
  • Straumann A, Spichtin HP, Bernoulli R et al. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz. Med. Wochenschr.124, 1419–1429 (1994).
  • Winter HS, Madara JL, Stafford RJ et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology83, 818–823 (1982).
  • Furuta GT, Liacouras CA, Collins MH et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology133, 1342–1363 (2007).
  • Dobbins JW. Eosinophilic gastroenteritis with esophageal involvement. Gastroenterology72, 1312 (1977).
  • Ureles AL, Alschibaja T, Lodico D, Stabins SJ. Idiopathic eosinophilic infiltration of the gastrointestinal tract, diffuse and circumscribed. Am. J. Med.30, 899 (1961).
  • Simon D, Marti H, Heer P et al. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J. Allergy Clin. Inmunol.115, 1090–1092 (2005).
  • Picus D, Frank P. Eosinophilic esophagitis. AJR Am. J. Roentgenol.136, 1001–1003 (1981).
  • Kelly KJ, Lazenby AJ, Rowe PC et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology109, 1503–1512 (1995).
  • Moawad FJ, Veerappan G, Lake JM et al. The correlation between eosinophilic oesophagitis and aeroallergens. Aliment. Pharmacol. Ther.31, 509–515 (2010).
  • Cherian S, Smith NM, Forbes DA. Rapidily increasing prevalence of eosinophilic esophagitis in Western Australia. Arch. Dis. Child.91, 1000–1004 (2006).
  • Liacouras CA, Spergel JM, Ruchelli E et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin. Gastroenterol. Hepatol.3, 1198–1206 (2005).
  • Garn H, Renz H. Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology212, 441–452 (2007).
  • Straumann A, Bauer M, Fischer B et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J. Allergy Clin. Immunol.108, 954–961 (2001).
  • Weller PF, Lim K, Wan HC et al. Role of the eosinophil in allergic reactions. Eur. Respir. J. Suppl.22, 109s–115s (1996).
  • Gleich GJ, Kita H. Bronchial asthma: lessons from murine models. Proc. Natl Acad. Sci. USA94, 2101–2102 (1997).
  • Cieslewicz G, Tomkinson A, Adler A et al. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J. Clin. Invest.104, 301–308 (1999).
  • Gharaee-Kermani M, McGarry B, Lukacs N et al. The role of IL-5 in bleomycin-induced pulmonary fibrosis. J. Leukoc. Biol.64, 657–666 (1998).
  • Phipps S, Ying S, Wangoo A et al. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodelling in human atopic skin. J. Immunol.169, 4604–4612 (2001).
  • Rothenberg ME. Eosinophilic gastrointestinal disorders. J. Allergy Clin. Inmunol.113, 11–28 (2004).
  • Rothenberg ME, Mishra A, Brandt EB et al. Gastroeintestinal eosinophils. Inmunol. Rev.179, 139–155 (2001).
  • Mishra A, Hogan SP, Brandt EB et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J. Clin. Invest.107, 83–90 (2001).
  • Mishra A, Hogan SP, Brandt EB et al. IL-5 promotes eosinophil trafficking to the esophagus. J. Inmunol.168, 2464–2469 (2002).
  • Akei HS, Mishra A, Blanchard C et al. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology129, 985–994 (2005).
  • Yamazaki K, Murray JA, Arora AS et al. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig. Dis. Sci.51, 1934–1941 (2006).
  • Bullock JZ, Villanueva JM, Blanchard C et al. Interplay of adaptive Th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J. Pediatr. Gastroenterol. Nutr.45, 22–31 (2007).
  • Straumann A, Conus S, Grzonka P et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial. Gut59, 21–30 (2010).
  • Lucendo AJ, De Rezende L, Comas C et al. Treatment with topic steroids downregulates IL-5, eotaxin-1/CCL11 and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am. J. Gastroenterol.103, 2184–2193 (2008).
  • Schmid-Grendelmeier P, Altznauer F, Fischer B et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J. Immunol.169, 1021–1027 (2002).
  • Blanchard C, Mingler MK, Vicario M et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J. Allergy Clin. Immunol.120, 1292–1300 (2007).
  • Neilsen CV, Bryce PJ. Interleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils. Clin. Exp. Allergy40(3), 427–434 (2010).
  • Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology125, 1419–1427 (2003).
  • Barner M, Mohrs M, Brombacher F et al. Differences between IL-4R α-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol.8, 669–672 (1998).
  • Vicario M, Blanchard C, Stringer KF et al. Local B cells and IgE production in the esophageal mucosa in eosinophilic esophagitis. Gut59, 12–20 (2010).
  • Zimmermann N, Hogan SP, Mishra A et al. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J. Immunol.165, 5839–5846 (2000).
  • Blanchard C, Wang N, Stringer KF et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest.116, 536–547 (2006).
  • van Wetering S, Zuyderduyn S, Ninaber DK et al. Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13. Mol. Immunol.44, 803–811 (2007).
  • Hogan SP, Mishra A, Brandt EB et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflamation. Nat. Inmunol.2, 353–360 (2001).
  • Fujiwara H, Morita A, Kobayashi H et al. Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis. Ann. Allergy Asthma Immunol.89, 429–432 (2005).
  • Gupta SK, Fitzgerald JF, Kondratyuk T et al. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J. Pediatr. Gastroenterol. Nutr.42, 22–26 (2006).
  • Bhattacharya B, Carlsten J, Sabo E et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum. Pathol.38, 1744–1753 (2007).
  • Kitaura M, Suzuki N, Imai T et al. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J. Biol. Chem.274, 27975–27980 (1999).
  • Kagami S, Saeki H, Komine M et al. Interleukin-4 and interleukin-13 enhances CCL26 production in a human keratinocyte cell line HaCaT cells. Clin. Exp. Immunol.141, 459–466 (2005).
  • Lucendo AJ, Navarro M, Comas C et al. Immunophenotypic characterisation and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the disease’s cellular mechanisms and the esophagus’s immunological capacity. Am. J. Surg. Pathol.31, 598–606 (2007).
  • Fillon S, Robinson ZD, Colgan SP et al. Epithelial function in EGID. Immunol. Allergy Clin. North Am.29, 171–178 (2009).
  • Blanchard C, Rothenberg ME. Chemotactic factors associated with eosinophilic gastrointestinal diseases. Immunol. Allergy Clin. North Am.29, 141–148 (2009).
  • Mulder DJ, Pacheco I, Hurlbut DJ et al. FGF9-iduced proliferative response to eosinophilic inflammation in oesophagitis. Gut58, 166–173 (2009).
  • Ravelli AM, Villanacci V, Ruzzenenti N et al. Dilated intercellular spaces: a major morphological feature of esophagitis. J. Pediatr. Gastroenterol. Nutr.42, 510–515 (2006).
  • Aceves SS, Broide DH. Airway fibrosis and angiogenesis due to eosinophil trafficking in chronic asthma. Curr. Mol. Med.8, 350–358 (2008).
  • Mishra A, Wang M, Pemmaraju VR et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology134, 204–214 (2008).
  • Chehade M, Sampson HA, Morotti RA et al. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J. Pediatr. Gastroenterol. Nutr.45, 319–328 (2007).
  • Aceves SS, Newbury RO, Dohil R et al. Esophageal remodeling in paediatric eosinophilic esophagitis. J. Allergy Clin. Immunol.119, 206–212 (2007).
  • Aceves SS, Newbury RO, Chen D et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy65, 109–116 (2010).
  • Wershil BK. Exploring the role of mast cells in eosinophilic esophagitis. Allergy Clin. North Am.29, 189–195 (2009).
  • Lucendo AJ, Bellón T, Lucendo B. The role of mast cells in eosinophilic esophagitis. Pediatr. Allergy Immunol.20, 512–518 (2009).
  • Kirsch R, Bokhary R, Marcon MA et al. Activated mucosal mast-cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J. Pediatr. Gastroenterol. Nutr.44, 20–26 (2007).
  • Lucendo AJ. Immunopathological mechanisms of eosinophilic oesophagitis. Allergol. Immunopathol. (Madr.)36, 215–227 (2008).
  • Montero Vega MT. New aspects on inflammation in allergic diseases. Allergol. Inmunopathol. (Madr.)34, 156–179 (2006).
  • Jutel M, Blaser K, Akdis CA. The role of histamine in regulation of immune responses. Chem. Immunol. Allergy91, 174–187 (2006).
  • Sayed BA, Brown MA. Mast cells as modulators of T-cell responses. Immunol. Rev.217, 53–64 (2007).
  • Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an overview. Methods Mol. Biol.315, 13–34 (2006).
  • Lucendo Villarín AJ, De Rezende L. [Eosinophilic esophagitis. Review of current clinical and physiopathological concepts.] Gastroenterol. Hepatol.30, 234–241 (2007).
  • Kinet JP. The essential role of mast cells in orchestrating inflammation. Immunol Rev.217, 5–7 (2007).
  • Teitelbaum J, Fox V, Twarog F et al. Eosinophilic esophagitis in children: inmunopathological analysis and response to fluticasone propionate. Gastroenterology122, 1216–1225 (2002).
  • Straumann A, Bussmann C, Conus S et al. Anti-TNF-α (infliximab) therapy for severe adult eosinophilic esophagitis. J. Allergy Clin. Immunol.122, 425–427 (2008).
  • Rothenberg ME, Mishra A, Collins MH et al. Pathogenesis and clinical features of eosinophilic esophagitis. J. Allergy Clin. Inmunol.108, 891–894 (2001).
  • Arora AS, Yamazaki K. Eosinophilic esophagitis: asthma of the esophagus? Clin. Gastroenterol. Hepatol.2, 523–530 (2004).
  • Merwat SN, Spechler SJ. Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis? Am. J. Gastroenterol.104, 1902 (2009).
  • Bohle B. T lymphocytes and food allergy. Mol. Nutr. Food Res.48, 424–433 (2004).
  • Hong SJ, Michael JG, Fehringer A et al. Pepsin-digested peanut contains T-cell epitopes but not IgE epitopes. J. Allergy Clin. Immunol.104, 473–478 (1999).
  • Haselden BM, Kay AB, Larche M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J. Exp. Med.189, 1885–1894 (1999).
  • Collins MH, Blanchard C, Albonia JP et al. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Ciln. Gastroenterol. Hepatol.6, 621–629 (2008).
  • Martín-Muñoz MF, Lucendo AJ, Navarro M et al. Food allergy and eosinophilic esophagitis: two cases studies. Digestion74, 49–54 (2006).
  • Verzegnassi F, Bua J, De Angelis P et al. Eosinophilic oesophagitis and coeliac disease: is it just a casual association? Gut56(7), 1029–1030 (2007).
  • Leslie C, Mews C, Charles A et al. Celiac disease and eosinophilic esophagitis: a true association. J. Pediatr. Gastroenterol. Nutr. (2009) (Epub ahead of print).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.